Anju Singh

579 total citations
18 papers, 480 citations indexed

About

Anju Singh is a scholar working on Organic Chemistry, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Anju Singh has authored 18 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 6 papers in Molecular Biology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Anju Singh's work include Bacillus and Francisella bacterial research (5 papers), Research on Leishmaniasis Studies (4 papers) and Synthesis and biological activity (3 papers). Anju Singh is often cited by papers focused on Bacillus and Francisella bacterial research (5 papers), Research on Leishmaniasis Studies (4 papers) and Synthesis and biological activity (3 papers). Anju Singh collaborates with scholars based in United States, India and Singapore. Anju Singh's co-authors include Nasimul Hoda, Timothy J. Sellati, Mudasir Maqbool, Mohammad Mobashir, Tabassum Rahman, Karsten R. O. Hazlett, Edmund J. Gosselin, Ashutosh Shandilya, Ehtesham Jameel and B. Jayaram and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Chemical Communications.

In The Last Decade

Anju Singh

17 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anju Singh United States 12 253 162 85 80 68 18 480
Valmir Fadel Brazil 10 220 0.9× 35 0.2× 53 0.6× 77 1.0× 53 0.8× 22 350
Lauren R. H. Krumpe United States 14 459 1.8× 45 0.3× 80 0.9× 30 0.4× 15 0.2× 22 631
Krishnagopal Maiti India 11 222 0.9× 135 0.8× 54 0.6× 58 0.7× 3 0.0× 17 355
Marjorie H. Barnes United States 15 445 1.8× 97 0.6× 94 1.1× 41 0.5× 15 0.2× 26 645
Lisa A. Checkley United States 12 201 0.8× 45 0.3× 52 0.6× 12 0.1× 53 0.8× 21 505
Barbara Giabbai Italy 11 229 0.9× 28 0.2× 54 0.6× 46 0.6× 50 0.7× 17 407
Guan-Ping Yu China 10 198 0.8× 70 0.4× 108 1.3× 40 0.5× 12 0.2× 36 332
Monika Jankute United Kingdom 10 263 1.0× 70 0.4× 240 2.8× 17 0.2× 11 0.2× 13 534
Gaëlle Michaud Switzerland 8 349 1.4× 172 1.1× 12 0.1× 83 1.0× 12 0.2× 10 415
Pooja Gopal Singapore 17 461 1.8× 84 0.5× 354 4.2× 23 0.3× 30 0.4× 21 712

Countries citing papers authored by Anju Singh

Since Specialization
Citations

This map shows the geographic impact of Anju Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anju Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anju Singh more than expected).

Fields of papers citing papers by Anju Singh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anju Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anju Singh. The network helps show where Anju Singh may publish in the future.

Co-authorship network of co-authors of Anju Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Anju Singh. A scholar is included among the top collaborators of Anju Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anju Singh. Anju Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Singh, Anju, et al.. (2025). Triazole-based STING inhibitors. Bioorganic & Medicinal Chemistry. 132. 118484–118484.
2.
Singh, Anju, et al.. (2024). Robust leishmanicidal upshot of some new diphenyl triazine-based molecules. RSC Advances. 14(31). 22587–22597. 1 indexed citations
3.
4.
Maqbool, Mudasir, et al.. (2021). Unravelling the potency of triazole analogues for inhibiting α-synuclein fibrillogenesis andin vitrodisaggregation. Organic & Biomolecular Chemistry. 19(7). 1589–1603. 8 indexed citations
5.
Singh, Anju, et al.. (2020). Quinoline carboxamide core moiety-based compounds inhibit P. falciparumfalcipain-2: Design, synthesis and antimalarial efficacy studies. Bioorganic Chemistry. 108. 104514–104514. 23 indexed citations
6.
Griner, Lesley A. Mathews, Janani Sundaresan, Zhiya Yu, et al.. (2020). Identification of Small Molecule Enhancers of Immunotherapy for Melanoma. Scientific Reports. 10(1). 5688–5688. 6 indexed citations
7.
Singh, Anju, et al.. (2019). Quinoline-triazole hybrids inhibit falcipain-2 and arrest the development ofPlasmodium falciparumat the trophozoite stage. RSC Advances. 9(67). 39410–39421. 25 indexed citations
8.
Xu, Dawei, Weike Chen, Carolyn R. Sturge, et al.. (2018). Fabrication and Microscopic and Spectroscopic Characterization of Cytocompatible Self-Assembling Antimicrobial Nanofibers. ACS Infectious Diseases. 4(9). 1327–1335. 41 indexed citations
9.
Kumar, Jitendra, Anju Singh, Ashutosh Shandilya, et al.. (2018). Pyrimidine‐Triazolopyrimidine and Pyrimidine‐Pyridine Hybrids as Potential Acetylcholinesterase Inhibitors for Alzheimer's Disease. ChemistrySelect. 3(2). 736–747. 32 indexed citations
10.
Singh, Anju, Sivakumar Periasamy, Meenakshi Malik, et al.. (2017). Necroptotic debris including damaged mitochondria elicits sepsis-like syndrome during late-phase tularemia. Cell Death Discovery. 3(1). 17056–17056. 11 indexed citations
11.
Kristjánsdóttir, Kolbrún, Donald J. Wolfgeher, Tiffany M. Zarrella, et al.. (2017). Differential Growth of Francisella tularensis, Which Alters Expression of Virulence Factors, Dominant Antigens, and Surface-Carbohydrate Synthases, Governs the Apparent Virulence of Ft SchuS4 to Immunized Animals. Frontiers in Microbiology. 8. 1158–1158. 19 indexed citations
12.
Singh, Anju, Mudasir Maqbool, Mohammad Mobashir, & Nasimul Hoda. (2016). Dihydroorotate dehydrogenase: A drug target for the development of antimalarials. European Journal of Medicinal Chemistry. 125. 640–651. 55 indexed citations
13.
Kumar, Jitendra, Poonam Meena, Anju Singh, et al.. (2016). Synthesis and screening of triazolopyrimidine scaffold as multi-functional agents for Alzheimer's disease therapies. European Journal of Medicinal Chemistry. 119. 260–277. 63 indexed citations
14.
Xu, Dawei, Linhai Jiang, Anju Singh, et al.. (2014). Designed supramolecular filamentous peptides: balance of nanostructure, cytotoxicity and antimicrobial activity. Chemical Communications. 51(7). 1289–1292. 61 indexed citations
15.
Singh, Anju, Tabassum Rahman, Meenakshi Malik, et al.. (2013). Discordant Results Obtained with Francisella tularensis during In Vitro and In Vivo Immunological Studies Are Attributable to Compromised Bacterial Structural Integrity. PLoS ONE. 8(3). e58513–e58513. 27 indexed citations
16.
Zarrella, Tiffany M., Anju Singh, Constantine Bitsaktsis, et al.. (2011). Host-Adaptation of Francisella tularensis Alters the Bacterium's Surface-Carbohydrates to Hinder Effectors of Innate and Adaptive Immunity. PLoS ONE. 6(7). e22335–e22335. 57 indexed citations
17.
Shim, Jae‐Hyuck, Matthew B. Greenblatt, Anju Singh, et al.. (2011). Administration of BMP2/7 in utero partially reverses Rubinstein-Taybi syndrome–like skeletal defects induced by Pdk1 or Cbp mutations in mice. Journal of Clinical Investigation. 122(1). 91–106. 18 indexed citations
18.
Periasamy, Sivakumar, Anju Singh, Bikash Sahay, et al.. (2011). Development of tolerogenic dendritic cells and regulatory T cells favors exponential bacterial growth and survival during early respiratory tularemia. Journal of Leukocyte Biology. 90(3). 493–507. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valmir Fadel Breakdown of academic impact, for papers by Lauren R. H. Krumpe Breakdown of academic impact, for papers by Krishnagopal Maiti Breakdown of academic impact, for papers by Marjorie H. Barnes Breakdown of academic impact, for papers by Lisa A. Checkley Breakdown of academic impact, for papers by Barbara Giabbai Breakdown of academic impact, for papers by Guan-Ping Yu Breakdown of academic impact, for papers by Monika Jankute Breakdown of academic impact, for papers by Gaëlle Michaud Breakdown of academic impact, for papers by Pooja Gopal
Rankless by CCL
2026